Mar 19, 2025
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA
Nov 17, 2020
ConcertAI Announces New Pharma Collaboration to Use Real-World Data and AI Analytics to Optimize Cancer Care and Improve Patient Outcomes
Oct 28, 2020
Pancreatic Cancer Action Network Announces New Industry Partner To Accelerate New Therapies To Market Through Precision Promise Clinical Trial Platform
Oct 03, 2020
Novartis announces five-year data that reinforce the safety and efficacy profile of Aimovig® (erenumab-aooe) in adult patients with episodic migraine
Aug 13, 2020
Novartis announces FDA filing acceptance of Xolair® (omalizumab) prefilled syringe for self-administration across all indications
Aug 13, 2020
Sosei Heptares Operational Highlights and Consolidated Results for the First Half 2020
Jun 29, 2020
New Agreements to Expand Access to 20 Lifesaving Cancer Medicines for Countries in Sub-Saharan Africa and Asia
Jun 19, 2020
Global Spinal Muscular Atrophy Market Outlook to 2027 - Advent of Oral mRNA Splicer for Treatment
Jun 19, 2020
Global Transdermal Skin Patches Market 2020-2030 - Featuring Profiles of Mylan Pharma, Hisamitsu Pharma, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, and More
Jun 16, 2020
TrialSpark announces launch of Project Covalence, a clinical trial platform to rapidly test drugs and diagnostics for COVID-19
Jun 16, 2020
CANbridge Pharmaceuticals Appoints Senior Vice President/Global Head of Business Development
Jun 16, 2020
COVID-19's Impact on the Cold & Flu Drugs Industry, Forecast to 2027
Jun 02, 2020
Global Organ Transplant Rejection Medications Market Outlook, 2027 - Key Trends, YoY Growth, Top Drugs, Leading Players
May 29, 2020
Novartis announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients treated with Tafinlar® + Mekinist® following surgery
May 27, 2020
Novartis announces new late-breaking ofatumumab data at EAN underscoring commitment to advancing treatment of relapsing forms of multiple sclerosis (RMS)
May 27, 2020
Novartis Kisqali® shows overall survival benefit in HR+/HER2- advanced breast cancer with consistent findings in patients with more aggressive disease
May 25, 2020
/R E P E A T -- New Wave Holdings Sponsors Non-Profit Coalition, Therapsil, to Launch a Medical Psilocybin Access Project for Canadians in Palliative Care/
May 24, 2020
New Wave Holdings Sponsors Non-Profit Coalition, Therapsil, to Launch a Medical Psilocybin Access Project for Canadians in Palliative Care
May 21, 2020
US Dermatophytic Onychomycosis Drug Forecast and Market Analysis 2020-2028, Featuring Actavis, Allergan and Topica Pharmaceuticals
May 15, 2020
Roche Becomes Founding Partner of BaseLaunch Phase II